Discovering a Common Goal,
Discovering a Cure

CONTACT  |  DONATE  |  E-NEWSLETTER  | 
  
DRUG NEWS

Research News
Drug News
Conference News
< Home



ALSTDI CEO Urges More Preclinical Testing Before Human ALS Trials
March 26, 2014
Each new candidate ALS therapy that is tested in patients sparks overwhelming hope across the ALS community. However, often these drugs are tested in human trials without sufficien...

NeuroQuest’s New Biomarker Technology Soon Coming to SC
March 25, 2014
An Israeli start-up company developing biomarkers for early detection of ALS and Alzheimer’s disease (AD) will establish its clinical development base in Charleston, South Caroli...

Final Results of Neuralstem Phase I Stem Cell Trial in ALS Published
March 17, 2014
The much-anticipated final results from Neuralstem’s Phase I safety trial of intraspinal neural stem cell transplantation for treating ALS were published in the March 7 issue of ...

$17M Series A Financing towards Ataxias Drug Development
March 17, 2014
Cambridge, MA-based Ataxion has secured $17M in series A financing from Biogen Idec and Atlas Venture. This new startup biotech company is focused on rare neurodegenerative disease...

Regulatory T Cells Targeted in Upcoming Clinical Trial
March 10, 2014
ALS patients with high numbers of circulating regulatory T cells appear to live longer and exhibit slower disease progression than most ALS patients. Could boosting the number of r...





The ALS Forum was developed by Prize4Life, Inc.
P.O. Box 425783 | Cambridge, MA 02142 | 617.500.7527
© 2014 Prize4Life, Inc.
Identified content provided through
a partnership with the Alzforum